...
首页> 外文期刊>Pharmacoepidemiology and drug safety >Should cases with a 'known' cause of their disease be excluded from study? (commentary).
【24h】

Should cases with a 'known' cause of their disease be excluded from study? (commentary).

机译:是否应将其“已知”病因的病例排除在研究范围之外? (评论)。

获取原文
获取原文并翻译 | 示例

摘要

Assigning a cause to an individual event is a natural impulse. This impulse sometimes finds its way into epidemiologic research, if researchers assign a specific cause to some cases of a disease under study. In epidemiologic studies of drug effects, assigning a cause to specific cases is often used as a reason to exclude these cases from cohort or case-control studies, because the disease in these cases is thought to be the result of a 'known cause'. These exclusions are invalid. It is always valid, however, to exclude all subjects with 'known' causes from a study, cases from the numerator and the people or person-time at risk from the denominator (or from the control series in a case-control study). If the exclusions from the denominator would be negligibly small or the relative number of excluded cases with 'known' causes is small, then the exclusion of just the cases with 'known' causes will introduce little bias.
机译:为单个事件分配原因是自然的冲动。如果研究人员将特定原因分配给正在研究的某些疾病,这种冲动有时会进入流行病学研究。在药物作用的流行病学研究中,通常将原因分配给特定病例,作为将这些病例排除在队列研究或病例对照研究之外的原因,因为这些病例中的疾病被认为是“已知原因”的结果。这些排除无效。但是,从研究中排除所有具有“已知”原因的受试者,分子中的病例以及分母(或病例对照研究中的对照系列)中有风险的人或人/人时始终是有效的。如果分母中的排除项很小,或者排除了具有“已知”原因的病例的相对数量很小,那么仅排除具有“已知”原因的病例将不会带来多少偏差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号